Pathway Medical Technologies’ artery-clearing system gets FDA approval


August 6, 2008 · 12:54 PM

  • 0
  • Print Story
  • Letter/Editor

The Food and Drug Administration has approved Pathway Medical Technologies’ “PV Atherectomy System,” Thomas Clement, CEO of the Kirkland-based company, announced last week. The system is designed to treat patients with peripheral artery disease by removing hard and soft diseased tissue and restoring circulation in the peripheral arteries.

In mid-April, Pathway said it would use a $24.5 million venture financing round to build a sales and manufacturing organization for the commercialization of its system.

Clement said Pathway would bring the product to market during the fourth quarter of the year. Currently, he said, the company is working on hiring a sales and marketing force of 22 to sell the system. The company has 120 on staff.

Comment on this story.

COMMENTING RULES: We encourage an open exchange of ideas in our online community, but we ask you to follow our guidelines for respecting community standards. In a nutshell, don't say anything you wouldn't want your mother to read.

So keep your comments:

  • Civil
  • Smart
  • On-topic
  • Free of profanity

We ask that all participants own their words by logging in with their Facebook account. It's a simple process that will take seconds and helps keep our comments free of trolls, cranks, and “drive-by” commenters. We reserve the right to remove comments from anyone using screen names, pseudonyms or false identities. Please see our FAQ if you have questions or concerns about using Facebook to comment.

blog comments powered by Disqus